Hereditary nonpolyposis colorectal cancer surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(One intermediate revision by one other user not shown)
Line 4: Line 4:


==Overview==
==Overview==
[[Surgery]] is the mainstay of treatment for [[hereditary nonpolyposis colorectal cancer]]. Surgical resection is recommended among patients with hereditary nonpolyposis colorectal cancer because of the high rate of metachronous [[colorectal cancer]]. Subtotal [[colectomy]] with ileorectal [[anastomosis]] and postsurgical [[Endoscopy|endoscopic]] [[rectal]] surveillance are advised when [[colorectal cancer]] develops in the setting of hereditary nonpolyposis colorectal cancer.
[[Surgery]] is the mainstay of treatment for hereditary nonpolyposis colorectal cancer. [[Surgery|Surgical]] [[resection]] is recommended for [[Patient|patients]] with hereditary nonpolyposis colorectal cancer because of the high rate of metachronous [[colorectal cancer]]. [[colectomy|Subtotal colectomy]] with [[Ileum|ileo]]-[[rectal]] [[anastomosis]] and [[Surgery|postsurgical]] [[Endoscopy|endoscopic]] [[rectal]] surveillance are advised when [[colorectal cancer]] develops in the setting of hereditary nonpolyposis colorectal cancer.


==Surgery==
==Surgery==


*Surgical resection is recommended among patients with hereditary nonpolyposis colorectal cancer because of the high rate of metachronous colorectal cancer.  
*[[Surgery|Surgical]] [[resection]] is recommended for [[Patient|patients]] with hereditary nonpolyposis colorectal cancer because of the high rate of metachronous [[colorectal cancer]].  
*Common surgical techniques for the resection of hereditary nonpolyposis colorectal cancer, may include:
*Common [[Surgery|surgical]] techniques for the [[resection]] of hereditary nonpolyposis colorectal cancer include:
:*Subtotal colectomy with ileorectal anastomosis and postsurgical endoscopic rectal surveillance (surgical treatment of choice in the setting of hereditary nonpolyposis colorectal cancer)
:*[[Colectomy|Subtotal colectomy]] with [[Ileum|ileo]]-[[rectal]] [[anastomosis]] and [[Surgery|postsurgical]] [[Endoscopy|endoscopic]] [[rectal]] surveillance ([[Surgery|surgical]] treatment of choice in the setting of hereditary nonpolyposis colorectal cancer)
:*[[Proctocolectomy]] with [[ileostomy]]
:*[[Proctocolectomy]] with [[ileostomy]]
:*Colectomy with ileo-rectal [[anastomosis]] and/or [[proctocolectomy]] with [[Ileo-anal pouch|ileo-anal "pouch]]"<ref name="lynch">Kladny J, Lubinski J. Lynch syndrome (hereditary nonpolyposis colorectal cancer ). Hered Cancer Clin Pract. 2008;6(2):99-102.</ref>  
:*[[Colectomy]] with [[Ileum|ileo]]-[[rectal]] [[anastomosis]] and/or [[proctocolectomy]] with [[Ileo-anal pouch|ileo-anal "pouch]]"<ref name="lynch">Kladny J, Lubinski J. Lynch syndrome (hereditary nonpolyposis colorectal cancer ). Hered Cancer Clin Pract. 2008;6(2):99-102.</ref>  
:*Proctocolectomy with [[ileostomy]]  
:*[[Proctocolectomy]] with [[ileostomy]]  
:*[[Colectomy]] with ileorectal [[anastomosis]]
:*[[Colectomy]] with [[Ileum|ileo]]-[[rectal]] [[anastomosis]]
:*Proctocoloctomy with ileo-anal "pouch" S, J, W or H<ref name="lynch">Kladny J, Lubinski J. Lynch syndrome (hereditary nonpolyposis colorectal cancer ). Hered Cancer Clin Pract. 2008;6(2):99-102.</ref>
:*[[Proctocolectomy]] with [[Ileo-anal pouch|ileo-anal "pouch"]] S, J, W or H<ref name="lynch">Kladny J, Lubinski J. Lynch syndrome (hereditary nonpolyposis colorectal cancer ). Hered Cancer Clin Pract. 2008;6(2):99-102.</ref>
:*[[Hysterectomy]] and adnexectomy (in female hereditary nonpolyposis colorectal cancer patients) due to increased risk of primary [[Endometrial cancer|endometrial]] and [[Ovarian cancer|ovarian cancers]]
:*[[Hysterectomy]] and adnexectomy (in [[female]] hereditary nonpolyposis colorectal cancer [[Patient|patients]]) due to increased risk of primary [[Endometrial cancer|endometrial]] and [[Ovarian cancer|ovarian cancers]]
:*[[Endoscopy|Endoscopic]] [[polypectomy]] (recommended in the case of polyps which are benign and non-recurrent)
:*[[Endoscopy|Endoscopic]] [[polypectomy]] (recommended in the case of [[Polyp|polyps]] which are [[benign]] and non-recurrent)
*Surgical procedures for hereditary nonpolyposis colorectal cancer are characterized by increasing frequency of complications.  
*[[Surgery|Surgical]] procedures for hereditary nonpolyposis colorectal cancer are characterized by increasing frequency of [[Complication (medicine)|complications]].  
*Complex surgical procedures are related with higher number of complications, but lower recurrence rates.  
*Complex [[Surgery|surgical]] procedures are related with higher number of [[Complication (medicine)|complications]], but lower recurrence rates.  
*Patients with [[Adenoma|adenomas]] that are multiple and/or recurrent and/or of a significant degree of [[dysplasia]] and/or [[Villous adenoma|villous]], prophylactic colectomy should be considered.
*[[Prophylaxis|Prophylactic]] [[colectomy]] should be considered in [[Patient|patients]] with [[Adenoma|adenomas]] that are multiple and/or recurrent and/or of a significant degree of [[dysplasia]] and/or [[Villous adenoma|villous]].
*The high proportion of synchronous tumors (more than 15% of patients at the time of diagnosis) or metachronous tumors (about 45% during 10 years following surgery of the primary tumor) suggests that for preventive surgery as for surgery in patients from hereditary nonpolyposis colorectal cancer families with histopathologically diagnosed<ref name="lynch">Kladny J, Lubinski J. Lynch syndrome (hereditary nonpolyposis colorectal cancer). Hered Cancer Clin Pract. 2008;6(2):99-102.</ref>
*The high proportion of [[Synchronicity|synchronous]] [[Tumor|tumors]] (more than 15% of [[Patient|patients]] at the time of [[diagnosis]]) or metachronous [[Tumor|tumors]] (about 45% during 10 years following [[surgery]] of the primary [[tumor]]) [[Indication (medicine)|indicates]] [[Prevention (medical)|preventive]] [[surgery]] as for [[surgery]] in [[Patient|patients]] of hereditary nonpolyposis colorectal cancer.<ref name="lynch">Kladny J, Lubinski J. Lynch syndrome (hereditary nonpolyposis colorectal cancer). Hered Cancer Clin Pract. 2008;6(2):99-102.</ref>


Common surgical complications of hereditary nonpolyposis colorectal cancer, may include:  
Common [[Surgery|surgical]] [[Complication (medicine)|complications]] of hereditary nonpolyposis colorectal cancer may include:  
*Urinary tract abnormalities  
*[[Urinary system|Urinary tract]] abnormalities  
*Sexual dysfunction
*[[Sexual dysfunction]]


==Prophylactic Surgery==
==Prophylactic Surgery==


*The feasibility of prophylactic surgery of the [[Colon (anatomy)|colon]], [[uterus]], and [[Ovary|ovaries]] depends on a individual basis for hereditary nonpolyposis colorectal cancer patients.<ref name="pmid21037810">{{cite journal |vauthors=Gryfe R |title=Inherited colorectal cancer syndromes |journal=Clin Colon Rectal Surg |volume=22 |issue=4 |pages=198–208 |year=2009 |pmid=21037810 |pmc=2796102 |doi=10.1055/s-0029-1242459 |url=}}</ref>  
*The feasibility of [[Prophylaxis|prophylactic]] [[surgery]] of the [[Colon (anatomy)|colon]], [[uterus]], and [[Ovary|ovaries]] varies from [[patient]] to [[patient]].<ref name="pmid21037810">{{cite journal |vauthors=Gryfe R |title=Inherited colorectal cancer syndromes |journal=Clin Colon Rectal Surg |volume=22 |issue=4 |pages=198–208 |year=2009 |pmid=21037810 |pmc=2796102 |doi=10.1055/s-0029-1242459 |url=}}</ref>  
*In some cases screen-detected family members and symptomatic individuals (young adults) are eligible for prophylactic colorectal surgery.  
*In some cases screen-detected [[family]] members and [[symptomatic]] individuals (young [[Adult|adults]]) are eligible for [[Prophylaxis|prophylactic]] [[colorectal surgery]].  


*Prophylactic surgery should not be recommended to patients without any pathological changes of the colon even if such persons are carriers of a mutation.<ref name="pmid16421367">{{cite journal |vauthors=Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, Lu KH |title=Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome |journal=N. Engl. J. Med. |volume=354 |issue=3 |pages=261–9 |year=2006 |pmid=16421367 |doi=10.1056/NEJMoa052627 |url=}}</ref>
*[[Prophylaxis|Prophylactic]] [[surgery]] should not be recommended for [[Patient|patients]] without any [[Pathology|pathological]] changes in the [[Colon (anatomy)|colon]] even if such individuals are [[Carrier|carriers]] of a [[mutation]].<ref name="pmid16421367">{{cite journal |vauthors=Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, Lu KH |title=Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome |journal=N. Engl. J. Med. |volume=354 |issue=3 |pages=261–9 |year=2006 |pmid=16421367 |doi=10.1056/NEJMoa052627 |url=}}</ref>


==References==
==References==

Latest revision as of 13:56, 30 April 2019

Hereditary Nonpolyposis Colorectal Cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hereditary Nonpolyposis Colorectal Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hereditary nonpolyposis colorectal cancer surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hereditary nonpolyposis colorectal cancer surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hereditary nonpolyposis colorectal cancer surgery

CDC on Hereditary nonpolyposis colorectal cancer surgery

Hereditary nonpolyposis colorectal cancer surgery in the news

Blogs on Hereditary nonpolyposis colorectal cancer surgery

Directions to Hospitals Treating Hereditary nonpolyposis colorectal cancer

Risk calculators and risk factors for Hereditary nonpolyposis colorectal cancer surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]Ali Akram, M.B.B.S.[3]

Overview

Surgery is the mainstay of treatment for hereditary nonpolyposis colorectal cancer. Surgical resection is recommended for patients with hereditary nonpolyposis colorectal cancer because of the high rate of metachronous colorectal cancer. Subtotal colectomy with ileo-rectal anastomosis and postsurgical endoscopic rectal surveillance are advised when colorectal cancer develops in the setting of hereditary nonpolyposis colorectal cancer.

Surgery

Common surgical complications of hereditary nonpolyposis colorectal cancer may include:

Prophylactic Surgery

References

  1. 1.0 1.1 1.2 Kladny J, Lubinski J. Lynch syndrome (hereditary nonpolyposis colorectal cancer ). Hered Cancer Clin Pract. 2008;6(2):99-102.
  2. Gryfe R (2009). "Inherited colorectal cancer syndromes". Clin Colon Rectal Surg. 22 (4): 198–208. doi:10.1055/s-0029-1242459. PMC 2796102. PMID 21037810.
  3. Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, Lu KH (2006). "Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome". N. Engl. J. Med. 354 (3): 261–9. doi:10.1056/NEJMoa052627. PMID 16421367.


Template:WikiDoc Sources